Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Leukemia (15)
Nature Genetics (2)
Bone Marrow Transplantation (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (11)
Correspondence (4)
Reviews (2)
Amendments and Corrections (1)

Subject Check one or more subjects to show results from those subjects only.

Cancer
Diseases
Genetics
Health care
Medical research

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–18 of 18 results

Advanced filters: Author: C Graux Clear advanced filters

Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia

C. Graux
J. Cools
Anne Hagemeijer
Research12 Sept 2004
Nature Genetics

Volume: 36, P: 1084-1089
Large-scale association analysis identifies new risk loci for coronary artery disease

Panos Deloukas, Nilesh Samani and colleagues report a large-scale association analysis using the Metabochip array in 63,746 coronary artery disease cases and 130,681 controls. They identify 15 susceptibility loci, refine previous associations and use network analysis to highlight biological pathways.

Panos Deloukas
Stavroula Kanoni
Nilesh J Samani
Research02 Dec 2012
Nature Genetics

Volume: 45, P: 25-33
Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS

G. J. Ossenkoppele
D. A. Breems
M. Van Marwijk Kooy
Research04 Feb 2020
Leukemia

Volume: 34, P: 1751-1759
Rapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemia

W Deenik
H B Beverloo
J J Cornelissen
Correspondence06 Nov 2008
Leukemia

Volume: 23, P: 627-629
Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome

J. J. W. M. Janssen
B. Löwenberg
G. J. Ossenkoppele
Research22 Jul 2022
Leukemia

Volume: 36, P: 2189-2195
Prognostic value of high-sensitivity measurable residual disease assessment after front-line chemoimmunotherapy in chronic lymphocytic leukemia

Rémi Letestu
Abdelmalek Dahmani
Henry Jardel
Research15 Sept 2020
Leukemia

Volume: 35, P: 1597-1609
Adult T-cell acute lymphoblastic leukemias with IL7R pathway mutations are slow-responders who do not benefit from allogeneic stem-cell transplantation

Rathana Kim
Nicolas Boissel
Ludovic Lhermitte
Research28 Jan 2020
Leukemia

Volume: 34, P: 1730-1740
Comparison of mutated ABL1 and JAK2 as oncogenes and drug targets in myeloproliferative disorders

C Walz
N C P Cross
A Reiter
Reviews05 Jun 2008
Leukemia

Volume: 22, P: 1320-1334
Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia

C Graux
M Stevens-Kroef
H A Poirel
Research16 Oct 2008
Leukemia

Volume: 23, P: 125-133
Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS

G. J. Ossenkoppele
D. A. Breems
M. Van Marwijk Kooy
Amendments and Corrections30 Jul 2020
Leukemia

Volume: 34, P: 2820
Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40–60 years

J J Cornelissen
J Versluis
B Löwenberg
Research27 Nov 2014
Leukemia

Volume: 29, P: 1041-1050
Sequential administration of low dose 5-azacytidine (AZA) and donor lymphocyte infusion (DLI) for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) in relapse after allogeneic stem cell transplantation (SCT): a prospective study from the Belgian Hematology Society (BHS)

Xavier Poiré
Carlos Graux
Yves Beguin
Correspondence05 Oct 2021
Bone Marrow Transplantation

Volume: 57, P: 116-118
Translocation t(14;18) is not associated with inferior outcome in chronic lymphocytic leukemia

N Put
P Meeus
L Michaux
Correspondence19 Mar 2009
Leukemia

Volume: 23, P: 1201-1204
Transition from EML1-ABL1 to NUP214-ABL1 positivity in a patient with acute T-lymphoblastic leukemia

K De Keersmaecker
I Lahortiga
P Vandenberghe
Correspondence05 Oct 2006
Leukemia

Volume: 20, P: 2202-2204
Clinical, cytogenetic and molecular characteristics of 14 T-ALL patients carrying the TCRβ-HOXA rearrangement: a study of the Groupe Francophone de Cytogénétique Hématologique

B Cauwelier
H Cavé
F Speleman
Research12 Oct 2006
Leukemia

Volume: 21, P: 121-128
A new recurrent inversion, inv(7)(p15q34), leads to transcriptional activation of HOXA10 and HOXA11 in a subset of T-cell acute lymphoblastic leukemias

F Speleman
B Cauwelier
A Hagemeijer
Research27 Jan 2005
Leukemia

Volume: 19, P: 358-366
A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with ⩽30% blasts

G Garcia-Manero
M A Sekeres
O G Ottmann
ResearchOpen Access26 May 2017
Leukemia

Volume: 31, P: 2799-2806
Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast

C Graux
J Cools
A Hagemeijer
Reviews06 Jul 2006
Leukemia

Volume: 20, P: 1496-1510

Search

Search articles by subject, keyword or author

Show results from

Advanced search

Quick links

Explore articles by subject
Find a job
Guide to authors
Editorial policies

Nature.com

nature.com sitemap

About Nature Portfolio

About us
Press releases
Press office
Contact us

Discover content

Journals A-Z
Articles by subject
protocols.io
Nature Index

Publishing policies

Nature portfolio policies
Open access

Author & Researcher services

Reprints & permissions
Research data
Language editing
Scientific editing
Nature Masterclasses
Research Solutions

Libraries & institutions

Librarian service & tools
Librarian portal
Open research
Recommend to library

Advertising & partnerships

Advertising
Partnerships & Services
Media kits
Branded content

Professional development

Nature Awards
Nature Careers
Nature Conferences

Regional websites

Nature Africa
Nature China
Nature India
Nature Japan
Nature Middle East

Privacy Policy
Use of cookies
Legal notice
Accessibility statement
Terms & Conditions
Your US state privacy rights

Search

Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia

Large-scale association analysis identifies new risk loci for coronary artery disease

Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS

Rapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemia

Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome

Prognostic value of high-sensitivity measurable residual disease assessment after front-line chemoimmunotherapy in chronic lymphocytic leukemia

Adult T-cell acute lymphoblastic leukemias with IL7R pathway mutations are slow-responders who do not benefit from allogeneic stem-cell transplantation

Comparison of mutated ABL1 and JAK2 as oncogenes and drug targets in myeloproliferative disorders

Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia

Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS

Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40–60 years

Sequential administration of low dose 5-azacytidine (AZA) and donor lymphocyte infusion (DLI) for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) in relapse after allogeneic stem cell transplantation (SCT): a prospective study from the Belgian Hematology Society (BHS)

Translocation t(14;18) is not associated with inferior outcome in chronic lymphocytic leukemia

Transition from EML1-ABL1 to NUP214-ABL1 positivity in a patient with acute T-lymphoblastic leukemia

Clinical, cytogenetic and molecular characteristics of 14 T-ALL patients carrying the TCRβ-HOXA rearrangement: a study of the Groupe Francophone de Cytogénétique Hématologique

A new recurrent inversion, inv(7)(p15q34), leads to transcriptional activation of HOXA10 and HOXA11 in a subset of T-cell acute lymphoblastic leukemias

A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with ⩽30% blasts

Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast

Search

Quick links